iCAN researchers identify new biomarker with potential to predict immunotherapy response in lung cancer
The newly discovered biomarker may help to distinguish which patients are more likely to benefit from treatment that helps the…
The newly discovered biomarker may help to distinguish which patients are more likely to benefit from treatment that helps the…
On 8 September 2021, iCAN organised the event Cancer touches everyone – Towards more personalised cancer care with genetic information,…
FICAN (Comprehensive Cancer Center Finland) and its coordinating unit, is seeking a Director of the Finnish Cancer Center. FICAN develops…
A series of webinars on ongoing cancer research projects to celebrate the 50th anniversary of the Finnish Cancer Society will…
Cancer impacts each and every one of us in some way. We are all affected by how cancer is treated…
In a large-scale study examining various types of cancer, precise information about the cancer tumor is being combined with the…
What is iCAN? How does it utilise the best health data in the world? How can organisations join the iCAN initiative?…
iCAN Scientific Director Kari Alitalo has been conferred the honorary title of Academician of Science by President Sauli Niinistö on…
Patient involvement and patient organizations play a significant role in the iCAN flagship. The goal is to actively involve patients…
Winner of the Cancer Challenge, Eva-Maria Strömsholm and first runner up, Mikko Viitanen presented their ideas on open European Research &…
End of content
End of content